NBE-Therapeutics
Research in cancer treatment.
Launch date
Employees
Market cap
-
Enterprise valuation
$1.3b (Public information from Dec 2020)
Company register number CH-270.4.003.576-2
Basel Canton of Basel-Stadt (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|
Revenues | 4.6m | 4.7m | 4.3m | 4.4m |
% growth | - | 1 % | (8 %) | 4 % |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
€2.8m | Series A | ||
€18.7m | Series B | ||
€17.3m | Series B | ||
* | $22.0m | Series C | |
€1.2b Valuation: €1.2b | Acquisition | ||
Total Funding | $64.7m |
Related Content
Recent News about NBE-Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.